Autoantibodies to the Rpp25 Component of the Th/To Complex are the Most Common Antibodies in Patients with Systemic Sclerosis without Antibodies Detectable by Widely Available Commercial Tests

被引:28
作者
Mahler, Michael
Satoh, Minoru
Hudson, Marie
Baron, Murray
Chan, Jason Y. F.
Chan, Edward K. L.
Wick, James
Fritzler, Marvin J.
机构
[1] INOVA Diagnost Inc, San Diego, CA USA
[2] Univ Occupat & Environm Hlth, Sch Hlth Sci, Dept Clin Nursing, Kitakyushu, Fukuoka 807, Japan
[3] Univ Florida, Dept Med & Patholo Immunol & Lab Med, Div Rheumatol & Clin Immunol, Gainesville, FL USA
[4] Univ Florida, Dept Oral Biol, Gainesville, FL USA
[5] McGill Univ, Dept Med, Montreal, PQ, Canada
[6] McGill Univ, Jewish Gen Hosp, Div Rheumatol, Montreal, PQ H3T 1E2, Canada
[7] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada
[8] Univ Calgary, Dept Med, Calgary, AB, Canada
关键词
TH/TO; INDIRECT IMMUNOFLUORESCENCE; SYSTEMIC SCLEROSIS; ELISA; AUTOANTIBODIES; EULAR SCLERODERMA TRIALS; RESEARCH GROUP DATABASE; ANTI-TH/TO; ANTINUCLEAR ANTIBODIES; AUTOIMMUNE-DISEASES; CLINICAL-FEATURES; COHORT; PREVALENCE; IMMUNOFLUORESCENCE; PERFORMANCE;
D O I
10.3899/jrheum.131450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Antinuclear antibodies (ANA) occur in up to 95% of patients with systemic sclerosis (SSc). In most, SSc-associated antibodies are detected (i.e., centromere, topoisomerase I, RNA polymerase III, PM/Scl, Ro52/TRIM21, and U1RNP), Ribonuclease P protein subunit p25, (Rpp25) is an autoantigenic component of the Th/To complex. The contribution of anti-Th/To and anti-Rpp25 antibodies to ANA positivity in patients with SSc remains unknown. Methods. Sera from 873 patients with SSc were tested for ANA, and SSc-associated antibodies were measured. Samples without antibodies to extractable nuclear antigens (ENA; n = 53, ANA+/ENA-), were analyzed by immunoprecipitation (IP) and metabolically labeled proteins and for anti-Rpp25 antibodies (n = 50) by a chemiluminescent immunoassay (CLIA) and Rpp25 ELISA. Results. Anti-Th/To antibodies occurred in 19/53 (36%), as determined by IP, and were the most common autoantibody in ANA+/ENA- SSc. Of those samples, 50/53 were available for additional testing by (ILIA and ELISA. Anti-Rpp25 antibodies were detected in 12 (24% CLIA) or 10 (20% ELISA) of 50 patients. Receiver-operating characteristic curve analysis showed similar discrimination between Th/To IP-positive (n = 19) and -negative samples (n = 31) by CLIA and ELISA (area under the curve 0.90 vs 0.87; p = 0.6691). The positive percent agreement between IP and CLIA or ELISA was 12/19 (63.2%, 95% CI 38.4-83.7%) or 10/19 (52.6%, 95% CI 73.3-94.2%), respectively. Negative percent agreement was 100% for both assays. Conclusion. Autoantibodies to the Th/To autoantigen are important in patients with SSc who have been considered negative for SSc-specific or SSc-associated antibodies by widely available commercial assays. Rpp25 can be considered a major target of anti-Th/To antibodies. Assays detecting anti-Th/To and anti-Rpp25 antibodies may be important in SSc.
引用
收藏
页码:1334 / 1343
页数:10
相关论文
共 43 条
[1]   International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies [J].
Agmon-Levin, Nancy ;
Damoiseaux, Jan ;
Kallenberg, Cees ;
Sack, Ulrich ;
Witte, Torsten ;
Herold, Manfred ;
Bossuyt, Xavier ;
Musset, Lucille ;
Cervera, Ricard ;
Plaza-Lopez, Aresio ;
Dias, Carlos ;
Sousa, Maria Jose ;
Radice, Antonella ;
Eriksson, Catharina ;
Hultgren, Olof ;
Viander, Markku ;
Khamashta, Munther ;
Regenass, Stephan ;
Coelho Andrade, Luis Eduardo ;
Wiik, Allan ;
Tincani, Angela ;
Ronnelid, Johan ;
Bloch, Donald B. ;
Fritzler, Marvin J. ;
Chan, Edward K. L. ;
Garcia-De la Torre, I. ;
Konstantinov, Konstantin N. ;
Lahita, Robert ;
Wilson, Merlin ;
Vainio, Olli ;
Fabien, Nicole ;
Sinico, Renato Alberto ;
Meroni, Pierluigi ;
Shoenfeld, Yehuda .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) :17-23
[2]   Autoantibodies to fibrillarin in systemic sclerosis (scleroderma) - An immunogenetic, serologic, and clinical analysis [J].
Arnett, FC ;
Reveille, JD ;
Goldstein, R ;
Pollard, KM ;
Leaird, K ;
Smith, EA ;
Leroy, EC ;
Fritzler, MJ .
ARTHRITIS AND RHEUMATISM, 1996, 39 (07) :1151-1160
[3]   Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis [J].
Bonroy, C. ;
Van Praet, J. ;
Smith, V. ;
Van Steendam, K. ;
Mimori, T. ;
Deschepper, E. ;
Deforce, D. ;
Devreese, K. ;
De Keyser, F. .
JOURNAL OF IMMUNOLOGICAL METHODS, 2012, 379 (1-2) :53-60
[4]   A new immunoprecipitation-real time quantitative PCR assay for anti-Th/To and anti-U3RNP antibody detection in systemic sclerosis [J].
Ceribelli, Angela ;
Satoh, Minoru ;
Chan, Edward K. L. .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (03)
[5]   Anti-Th/To Are Common Antinucleolar Autoantibodies in Italian Patients with Scleroderma [J].
Ceribelli, Angela ;
Cavazzana, Ilaria ;
Franceschini, Franco ;
Airo, Paolo ;
Tincani, Angela ;
Cattaneo, Roberto ;
Pauley, Brad A. ;
Chan, Edward K. L. ;
Satoh, Minoru .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (10) :2071-2075
[6]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[7]  
Fischer A, 2006, J RHEUMATOL, V33, P1600
[8]   Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F [J].
Fritzler, Marvin J. ;
Rattner, Jerome B. ;
Luft, LeeAnne M. ;
Edworthy, Steven M. ;
Casiano, Carlos A. ;
Peebles, Carol ;
Mahler, Michael .
AUTOIMMUNITY REVIEWS, 2011, 10 (04) :194-200
[9]   South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome [J].
Graf, Scott W. ;
Hakendorf, Paul ;
Lester, Sue ;
Patterson, Karen ;
Walker, Jenny G. ;
Smith, Malcolm. D. ;
Ahern, Michael J. ;
Roberts-Thomson, Peter J. .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2012, 15 (01) :102-109
[10]  
Hudson M, 2013, CLIN EXP RHEUMATOL